Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide vs Milrinone in Fontan Surgery
NCT00543309Phase 2Terminated
- Start
- Oct 2007
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nesiritide in congenital heart defects (CHD). Started Oct 2007; status: terminated.
02
Drugs
nesiritide
03
Conditions
congenital heart defects (CHD)
Beyond the preview
Go deeper on NCT00543309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543309.